Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126729151 | 12672915 | 1 | I | 20150825 | 20160810 | 20160822 | 20160822 | EXP | FR-NOVOPROD-505784 | NOVO NORDISK | 68.00 | YR | E | M | Y | 0.00000 | 20160822 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126729151 | 12672915 | 1 | PS | LEVEMIR | INSULIN DETEMIR | 1 | Subcutaneous | 22 U, QD | UNKNOWN | 21536 | 22 | DF | SOLUTION FOR INJECTION | QD | |||||
| 126729151 | 12672915 | 2 | SS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, QD | N | 0 | 20 | MG | QD | ||||||
| 126729151 | 12672915 | 3 | SS | METFORMINE | METFORMIN HYDROCHLORIDE | 1 | Oral | 3 DF, QD | 0 | 3 | DF | QD | |||||||
| 126729151 | 12672915 | 4 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 126729151 | 12672915 | 5 | SS | GLICLAZIDE | GLICLAZIDE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 126729151 | 12672915 | 6 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 126729151 | 12672915 | 7 | SS | VALSARTAN. | VALSARTAN | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 126729151 | 12672915 | 8 | SS | PERMIXON | SAW PALMETTO | 1 | Oral | 2 DF, QD | 0 | 2 | DF | QD | |||||||
| 126729151 | 12672915 | 9 | SS | KESTIN | EBASTINE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 126729151 | 12672915 | 10 | SS | LYRICA | PREGABALIN | 1 | Oral | 2 DF, QD | 0 | 2 | DF | QD | |||||||
| 126729151 | 12672915 | 11 | SS | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126729151 | 12672915 | 1 | Type 2 diabetes mellitus |
| 126729151 | 12672915 | 2 | Dyslipidaemia |
| 126729151 | 12672915 | 3 | Type 2 diabetes mellitus |
| 126729151 | 12672915 | 4 | Hypertension |
| 126729151 | 12672915 | 5 | Type 2 diabetes mellitus |
| 126729151 | 12672915 | 6 | Product used for unknown indication |
| 126729151 | 12672915 | 7 | Hypertension |
| 126729151 | 12672915 | 8 | Benign prostatic hyperplasia |
| 126729151 | 12672915 | 9 | Product used for unknown indication |
| 126729151 | 12672915 | 10 | Product used for unknown indication |
| 126729151 | 12672915 | 11 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126729151 | 12672915 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126729151 | 12672915 | Dyspnoea | |
| 126729151 | 12672915 | Interstitial lung disease | |
| 126729151 | 12672915 | Pulmonary fibrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |